LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr |
What is the latest Total Debt ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹1.07 Cr |
| Mar2023 | ₹2.00 Cr |
| Mar2022 | ₹2.04 Cr |
| Mar2021 | ₹0.52 Cr |
How is Total Debt of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹1.07 Cr | -46.57 | |
| Mar2023 | ₹2.00 Cr | -2.30 | |
| Mar2022 | ₹2.04 Cr | 293.08 | |
| Mar2021 | ₹0.52 Cr | - | |
Compare Total Debt of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,158.2 Cr | -0.2% | -7.4% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.2% |
-7.4% |
4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses